Search research articles
Contact Us
Filters
Showing results (11-20 of 113) with videos related to
Page
of 12
Sort By:
British Journal of Clinical Pharmacology
|
August 1, 1983
Mianserin metabolites
A C Altamura, T Melorio
Pharmacopsychiatry
|
January 14, 2015
May non-antipsychotic drugs improve cognition of schizophrenia patients?
M Buoli, A C Altamura
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1978
Renin and depression
A C Altamura, A Zanchetti
Psychopharmacologia
|
December 31, 1975
Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate
A C Altamura, A Morganti
Acta Neurologica
|
January 1, 1974
[Neurochemical, immunological and ultrastructural aspects of experimental epilepsy. Critical review of current data]
A C Altamura, P L Giordano
International Clinical Psychopharmacology
|
September 19, 2000
Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'
A C Altamura, S R Bareggi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 26, 2000
HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment
A C Altamura, F Boin, M Maes
Acta Psychiatrica Scandinavica
|
August 1, 1986
Prophylactic treatment with mianserin, therapy adherence and plasma monitoring. A case report
A C Altamura, M Mauri, G Guercetti
Epidemiology and Psychiatric Sciences
|
March 28, 2017
Exploring the neuroanatomical bases of psychotic features in bipolar disorder
E Maggioni, A C Altamura, P Brambilla
International Journal of Clinical Pharmacology Research
|
January 1, 1989
Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers
A C Altamura, F Colacurcio, S Marini
Page
of 12
Search research articles
Search
Showing results (11-20 of 113) with videos related to
Sort By:
Page
of 12
British Journal of Clinical Pharmacology
|
August 1, 1983
Mianserin metabolites
A C Altamura, T Melorio
Pharmacopsychiatry
|
January 14, 2015
May non-antipsychotic drugs improve cognition of schizophrenia patients?
M Buoli, A C Altamura
The British Journal of Psychiatry : the Journal of Mental Science
|
April 1, 1978
Renin and depression
A C Altamura, A Zanchetti
Psychopharmacologia
|
December 31, 1975
Plasma renin activity in depressed patients treated with increasing doses of lithium carbonate
A C Altamura, A Morganti
Acta Neurologica
|
January 1, 1974
[Neurochemical, immunological and ultrastructural aspects of experimental epilepsy. Critical review of current data]
A C Altamura, P L Giordano
International Clinical Psychopharmacology
|
September 19, 2000
Comment on 'reduced haloperidol does not interfere with antipsychotic activity of halperidol in the treatment of acute schizophrenia'
A C Altamura, S R Bareggi
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 26, 2000
HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment
A C Altamura, F Boin, M Maes
Acta Psychiatrica Scandinavica
|
August 1, 1986
Prophylactic treatment with mianserin, therapy adherence and plasma monitoring. A case report
A C Altamura, M Mauri, G Guercetti
Epidemiology and Psychiatric Sciences
|
March 28, 2017
Exploring the neuroanatomical bases of psychotic features in bipolar disorder
E Maggioni, A C Altamura, P Brambilla
International Journal of Clinical Pharmacology Research
|
January 1, 1989
Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers
A C Altamura, F Colacurcio, S Marini
Page
of 12